Characterizing Brain Oxygen Metabolism in Patients with Multiple Sclerosis with T2-Relaxation-Under-Spin-Tagging MRI

In this study, venous oxygen saturation and oxygen metabolic changes in multiple sclerosis (MS) patients were assessed using a recently developed T2-relaxation-under-spin-tagging (TRUST) magnetic resonance imaging (MRI), which measures the superior sagittal venous sinus blood oxygenation (Yv) and cerebral metabolic rate of oxygen (CMRO 2 ), an index of global oxygen consumption. Thirty patients with relapsing-remitting MS and 30 age-matched healthy controls were studied using TRUST at 3 T MR. The mean expanded disability status scale (EDSS) of the patients was 2.3 (range, 0 to 5.5). We found significantly increased Yv (P<0.0001) and decreased CMRO 2 (P=0.003) in MS patients (mean±s.d.: 65.9%±5.1% and 138.8±35.4 μmol per 100 g per minute) as compared with healthy control subjects (60.2%±4.0% and 180.2±24.8 μmol per 100 g per minute, respectively), implying decrease of oxygen consumption in MS. There was a significant positive correlation between Yv and EDSS and between Yv and lesion load in MS patients (n=30); on the contrary, there was a significant negative correlation between CMRO 2 and EDSS and between CMRO 2 and lesion load (n=12). There was no correlation between Yv and brain atrophy measures. This study showed preliminary evidence of the potential utility of TRUST in global oxygen metabolism. Our results of significant underutilization of oxygen in MS raise important questions regarding mitochondrial respiratory dysfunction and neurodegeneration of the disease.

[1]  G. Radda,et al.  Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. , 1982, Biochimica et biophysica acta.

[2]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[3]  E Mark Haacke,et al.  Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility‐weighted imaging at 3.0 Tesla , 2009, Journal of magnetic resonance imaging : JMRI.

[4]  R. Bryant,et al.  Magnetic relaxation in blood and blood clots , 1990, Magnetic resonance in medicine.

[5]  Glyn Johnson,et al.  Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. , 2005, AJNR. American journal of neuroradiology.

[6]  G. Johnson,et al.  Microvascular Abnormality in Relapsing-remitting Multiple Sclerosis: Perfusion Mr Imaging Findings in Normal-appearing White Matter , 2003 .

[7]  E. İdiman,et al.  Nitric oxide as an activity marker in multiple sclerosis , 2003, Journal of Neurology.

[8]  Yulin Ge,et al.  Baseline blood oxygenation modulates response amplitude: Physiologic basis for intersubject variations in functional MRI signals , 2008, Magnetic resonance in medicine.

[9]  Andrew M Blamire,et al.  MRI Reveals That Early Changes in Cerebral Blood Volume Precede Blood–Brain Barrier Breakdown and Overt Pathology in MS-like Lesions in Rat Brain , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  Peter C M van Zijl,et al.  Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T , 2007, Magnetic resonance in medicine.

[11]  M Quarantelli,et al.  A voxel-based morphometry study of disease severity correlates in relapsing–remitting multiple sclerosis , 2010, Multiple sclerosis.

[12]  D. Bourdette,et al.  Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis , 2009, Current neurology and neuroscience reports.

[13]  Xavier Golay,et al.  Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla , 2004, Magnetic resonance in medicine.

[14]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[15]  Albert Macovski,et al.  Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T , 1991 .

[16]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[17]  H. Lassmann,et al.  The role of nitric oxide in multiple sclerosis , 2002, The Lancet Neurology.

[18]  Peiying Liu,et al.  Calibration and validation of TRUST MRI for the estimation of cerebral blood oxygenation , 2012, Magnetic resonance in medicine.

[19]  Hanzhang Lu,et al.  Quantitative evaluation of oxygenation in venous vessels using T2‐Relaxation‐Under‐Spin‐Tagging MRI , 2008, Magnetic resonance in medicine.

[20]  R. Buxton,et al.  Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling , 1997, NMR in biomedicine.

[21]  F. Barkhof,et al.  CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis , 2004, Neurology.

[22]  H. Lassmann,et al.  Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? , 2005, Acta Neuropathologica.

[23]  Richard B. Buxton,et al.  Reproducibility of BOLD, perfusion, and CMRO2 measurements with calibrated-BOLD fMRI , 2007, NeuroImage.

[24]  R. Buxton.  Neuroenergetics Review Article , 2022 .

[25]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[26]  S. Moncada,et al.  Nitric oxide, cell bioenergetics and neurodegeneration , 2006, Journal of neurochemistry.

[27]  S. Kondo,et al.  Clinical significance of reduced cerebral metabolism in multiple sclerosis: A combined PET and MRI study , 1998, Annals of nuclear medicine.

[28]  R. Lisak.  Neurodegeneration in multiple sclerosis , 2007, Neurology.

[29]  Glyn Johnson,et al.  Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. , 2007, Archives of neurology.

[30]  A Macovski,et al.  1991 I.I. Rabi Award. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T. , 1991, Journal of magnetic resonance imaging : JMRI.

[31]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[32]  G. Enikolopov,et al.  Nitric oxide and multiple sclerosis , 2005, Current neurology and neuroscience reports.

[33]  T Asakura,et al.  NMR Relaxation Times of Blood: Dependence on Field Strength, Oxidation State, and Cell Integrity , 1987, Journal of computer assisted tomography.

[34]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[35]  B D Trapp,et al.  Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.

[36]  V. Borutaite,et al.  Serial Review: Nitric Oxide in Mitochondria Guest Editors: Christoph Richter and Matthias Schweizer NITRIC OXIDE INHIBITION OF MITOCHONDRIAL RESPIRATION AND ITS ROLE IN CELL DEATH , 2002 .

[37]  Stefan K. Piechnik,et al.  Sources of systematic bias in hypercapnia-calibrated functional MRI estimation of oxygen metabolism , 2007, NeuroImage.

[38]  Hanzhang Lu,et al.  Noninvasive quantification of whole‐brain cerebral metabolic rate of oxygen (CMRO2) by MRI , 2009, Magnetic resonance in medicine.

[39]  E. Moser,et al.  Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. , 1997, Cellular and molecular biology.

[40]  Xavier Golay,et al.  Measurement of tissue oxygen extraction ratios from venous blood T2: Increased precision and validation of principle , 2001, Magnetic resonance in medicine.